Publications

Export 5003 results:
Sort by: [ Author  (Asc)] Title Type Year
A B C [D] E F G H I J K L M N O P Q R S T U V W X Y Z   [Show ALL]
Z
Zaki, I., M. K. Abdelhameid, I. M. El-Deen, K. O. Mohamed, A. H. A. A. Wahab, and A. M. Ashmawy, "Design, synthesis and screening of 1, 2, 4-triazinone derivatives as potential antitumor agents with apoptosis inducing activity on MCF-7 breast cancer cell line", European Journal of Medicinal Chemistry, vol. 156, issue -, pp. 563-579, 2018.
Zamin, M., S. Fahad, A. M. Khattak, M. Adnan, F. Wahid, A. Raza, D. Wang, S. Saud, M. Noor, H. F. Bakhat, et al., "Developing the first halophytic turfgrasses for the urban landscape from native Arabian desert grass", Environmental Science and Pollution Research: Springer Berlin Heidelberg, pp. 1–15, 2019. Abstract
n/a
Zamin, M., S. Fahad, A. M. Khattak, M. Adnan, F. Wahid, A. Raza, D. Wang, S. Saud, M. Noor, H. F. Bakhat, et al., "Developing the first halophytic turfgrasses for the urban landscape from native Arabian desert grass", Environmental Science and Pollution Research: Springer Berlin Heidelberg, pp. 1–15, 2019. Abstract
n/a
Zamzam, M., H. Hafez, R. Khedr, S. Abouelnaga, M. Abdelbaki, L. Lehmann, L. C. Goumnerova, K. Houlahan, M. W. Kieran, and P. Pruden, Development of the joint Children’s Cancer Hospital Egypt (CCHE-57357) Dana-Farber Boston Children’s Hospital Pediatric Oncology Fellowship Program., : American Society of Clinical Oncology, 2017. Abstract
n/a
Zamzam, M., H. Hafez, R. Khedr, S. Abouelnaga, M. Abdelbaki, L. Lehmann, L. C. Goumnerova, K. Houlahan, M. W. Kieran, and P. Pruden, Development of the joint Children’s Cancer Hospital Egypt (CCHE-57357) Dana-Farber Boston Children’s Hospital Pediatric Oncology Fellowship Program., : American Society of Clinical Oncology, 2017. Abstract
n/a
Zappavigna, C., R. Shamloul, I. Cagiannos, R. Gerridzen, and A. J. Bella, "Development of Needs Assessment and Pilot Education Program for Delivery of Men's Health Care via Nurse Practitioners: ISMH World Congress 2010 Abstract 149", Journal of Men's Health, vol. 7, no. 3: Mary Ann Liebert, Inc. 140 Huguenot Street, 3rd Floor New Rochelle, NY 10801 USA, pp. 329–329, 2010. Abstract
n/a
Zarif, P., A. A. A. Mahmoud, M. M. Abdelhaq, H. M. S.Mikhail, and A. Farag, "Dexmedetomidine versus Magnesium Sulfate as Adjunct during Anesthesia for Laparoscopic Colectomy", Anesthesiology Research and Practice, 2016.
Zawilla, N. H., A. - A. M. Mohammad, S. M. E. - M. Aly, and others, "Determination of meloxicam in bulk and pharmaceutical formulations", Journal of pharmaceutical and biomedical analysis, vol. 32, no. 6: Elsevier, pp. 1135–1144, 2003. Abstract
n/a
Zawilla, N. H., A. A. M. Mohammad, N. M. El Kousy, and S. M. E. - M. Aly, "Determination of aceclofenac in bulk and pharmaceutical formulations", Journal of pharmaceutical and biomedical analysis, vol. 27, issue 1-2, pp. 243-251, 2002.
Zawilla, N. H., A. - A. M. Mohammad, and S. M. E. - M. Aly, "Determination of meloxicam in bulk and pharmaceutical formulations", Journal of pharmaceutical and biomedical analysis, vol. 32, issue 6, pp. 1135-1144, 2003.
Zayat, D. A. L. M., E. M. Attalla, H.S.Abouelenein, and M. A. Elnaggar, "Dosimetric comparison of Intensity-modulated radiotherapy versus 3D conformal radiotherapy in patients with prostate and pancreatic cancer", The Journal of Radiology. Photon, vol. 125, pp. 142-155, 2014. imrtversus_3dc__prostate__pancreatic_cancer.pdf
Zayat, D. M. A. L., E. M. Attalla, H. S. Abouelenein, and Y. M. Elkerm, "Dosimetric comparison of Intensity-modulated radiotherapy versus three dimensional conformal radiotherapy for patients with brain tumors. ", Open Journal of Radiology, vol. 4, issue 1, pp. 85-96, 2014. dosimetric_comparison_of.pdf
Zayat, D. A. L. M., E. M. Attalla, H.S.Abouelenein, and W. Khalil, "Dosimetric Comparison of Intensity-Modulated Radiotherapy versus 3D Conformal Radiotherapy in Patients with Head and Neck Cancer", Journal of Multidisciplinary Engineering Science and Technology (JMEST), vol. Vol. 2, issue Issue 4, pp. 678-682, 2015. dosimetric_comparison_of_imrt_vs_3dc_hn.pdf
Zayed, R. A., D. Omran, A. A. Zayed, and L. O. Elmessery, "Determinants of Infection Outcome in HCV-genotype 4", Viral Immunology, vol. 30 , issue 8, pp. 560-567, 2017.
Zayed, R. A., D. Omran, A. A. Zayed, and L. O. Elmessery, Determinants of infection outcome in HCV genotype- 4, , 2017.
Zayed, R. A., E. Rushdy, and D. ’aA. Saleh, "Detection of HCV RNA in the Peripheral Blood Mononuclear Cells of Serum HCV RNA Negative Egyptian Patients under Interferon Treatment.", Am J Med Sci., vol. 340, issue 6, pp. 435-438, 2010. Abstract

INTRODUCTION:
Despite recent success after the introduction of combination therapy with interferon (IFN)-α and ribavirin, approximately 60% of patients with hepatitis C virus (HCV) genotype 4 fail to respond. Resistance to antiviral therapy remains a serious problem in the management of chronic hepatitis C. In most patients, HCV RNA could be detected in peripheral blood mononuclear cell (PBMC).
OBJECTIVE:
The authors aimed to investigate the predictive value of HCV RNA in PBMC of patients with chronic hepatitis C after IFN treatment, which may act as the source of HCV reinfection of hepatic cells.
METHODS:
Seventy patients with chronic hepatitis C were treated with IFN plus ribavirin for 48 weeks; they all achieved clearance of HCV RNA from serum. At the end of treatment, PBMC and serum were examined by real-time polymerase chain reaction for detection of HCV RNA. Six months later, HCV RNA in serum was monitored to detect sustained virologic response.
RESULTS:
: Analysis revealed the presence of detectable HCV RNA in the PBMC of 27% of patients despite clearance of serum HCV RNA. During follow-up, 80% of the patients who became serum HCV positive 6 months after the end of treatment had detectable level of HCV RNA in PBMC at the end of treatment.
CONCLUSIONS:
The absence of HCV in the serum of patients by the end of treatment does not exclude future viremia. The patient might still be a source of infection to others. It is strongly encouraged to test for HCV in PBMC to detect lack of response to treatment and persisting infection.

Zayed, A., A. A. Awash, M. A. Esmail, H. A. Al-Mohamadi, M. Al-Salwai, A. Al-Jasari, I. Medhat, M. E. Morales-Betoulle, and A. Mnzava, "Detection of Chikungunya virus in Aedes aegypti during 2011 outbreak in Al Hodayda, Yemen", Acta tropica, vol. 123, no. 1: Elsevier, pp. 62–66, 2012. Abstract
n/a
Zeeneldin, A. A., A. A. Gaber, and F. M. Taha, "Does fasting during Ramadan trigger non-adherence to oral hormonal therapy in breast cancer patients?", Journal of the Egyptian National Cancer Institute, vol. 24, issue 3, pp. 133-7, 2012 Sep. Abstract

PURPOSE: To estimate the effect of fasting during Ramadan (the ninth lunar month) on adherence to oral hormonal therapies (OHT) among breast cancer (BC) patients.

PATIENTS AND METHODS: During Ramadan 2010, 139 BC patients were interviewed at the Egyptian National Cancer Institute. They were asked about fasting as well as intake of OHT in Ramadan and in the preceding month.

RESULTS: The median age was 50years and most patients were postmenopausal with good performance status and non-metastatic disease. The median number of fasting days was 18% and 93% of patients were fasting 80% or more of Ramadan. Tamoxifen and aromatase inhibitors were used in 64% and 36%, respectively. Adherence to OHT during Ramadan and its preceding month were 94.2% and 95.7%, respectively (p=0.77). In univariate analysis, non-adherence prior to Ramadan and shorter duration of OHT were predictors of non-adherence during Ramadan (P<0.001, 0.003, respectively). Fasting, age, performance status, presence of metastases and type of hormonal therapy were not good predictors of adherence.

CONCLUSIONS: While most of patients receiving OHT for BC are fasting during Ramadan, this does not negatively impact compliance with treatment.

Zeeneldin, A., N. Gad Elmawla, A. Elkhodary, and N. Allahloubi, Dose-dense chemotherapy versus conventional chemotyherapy as primary therapy in advanced breast cancer, , Cairo, Cairo, 2001.
Zeeneldin, A. A., A. A. Gaber, and F. M. Taha, "Does fasting during Ramadan trigger non-adherence to oral hormonal therapy in breast cancer patients?", Journal of the Egyptian National Cancer Institute: Elsevier, 2012. Abstract
n/a
Zeid, F. A., and H. Kuhn, "Der Einfluss von Kieselsaure auf die Halmstabilitat von Getride.", Zeitschrift für Landwirtschaftliche Forschung,, vol. 26, pp. 105–111, 1971. Abstract
n/a
Zeid, F. A., and H. Kuhn, "Der Einfluss von Kieselsaure auf die Halmstabilitat von Getride.", Zeitschrift für Landwirtschaftliche Forschung,, vol. 26, pp. 105–111, 1971. Abstract
n/a
Zein, H., and H. Omar, "Designing and Manufacturing of Miniature Savonius Wind ‎Turbine", International Engineering Conference and Exhibition IECE‎, Riyadh, Saudi Arabia‎, 5 December, 2017. 4th_paper.pdf
Tourism